Bali Muralidhar

Bali Muralidhar

Active Investor

Global Head of Life Sciences at Abingworth

London, England

Bali Muralidhar, Global Head of Life Sciences at Abingworth is an active investor based in London, England. This profile covers what Bali Muralidhar backs, at which stage, and how founders can reach out in 2026.

Investor type
VCPEInvestor
Stages
Series B
Invests in
Healthcare & BiotechDigital Health & HealthTechBiotech & PharmaSaaS & EnterpriseIoT & Connected DevicesGaming & EntertainmentMedia & ContentLegalTech
Location
London, England
Typical check
$3M
Past investments
74

Notable investments

Kesios TherapeuticsSpruce BiosciencesAmarinSyntaxinCRISPR TherapeuticsAttenuaBroncus TechnologiesJasper TherapeuticsSynosia TherapeuticsX4 PharmaceuticalsKspineAnjarium Biosciences

How to reach Bali Muralidhar

Angels and operators like Bali Muralidhar reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.

Frequently Asked Questions

What does Bali Muralidhar invest in?

Bali Muralidhar invests in Healthcare & Biotech, Digital Health & HealthTech, Biotech & Pharma and SaaS & Enterprise, typically at Series B. Match your sector and stage, then reach out with a personalized pitch.

How do I contact Bali Muralidhar?

Unlock Bali Muralidhar's verified email on Round Funded and send a personalized pitch. We surface only deliverable contacts so your outreach lands.

Similar investors

Browse all investorsIs this you? Email team@roundfunded.com to update or remove your profile.